 |
Finn Partners is working with the Africa Medical Supplies Platform, a non-profit initiative launched by the African Union in response to the COVID-19 pandemic.
The independent firm is supporting AMSP communication objectives in the UK, Europe and North America.
AMSP has received a commitment from The Bill and Melinda Gates Foundation to help secure nine million tablets of dexamethasone, a drug that has demonstrated reduction of mortality for COVID-19 patients in hospitals.
This agreement could benefit approximately one million people across Africa if they become hospitalized with COVID-related respiratory distress.
The drug will be distributed proportionately, without cost, across the continent. “This is yet another indicator of our commitment to communications around healthcare and the provision of services that help people live longer, healthier lives,” said Chantal Bowman-Boyles, Finn Partners' managing partner, Europe.
Finn Partners is O'Dwyer's No. 4 ranked firm with 2019 fees of $119.3M.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
